Laparoscopic splenectomy for hematological disorders.
OBJECTIVE
The aim of this prospective study was to evaluate the safety and feasibility of laparoscopic splenectomy (LS) in patients with hematological disorders of the spleen.


METHODS
Between 1999 and 2001, 15 patients (11 female and 4 male), with a mean age of 30 years, underwent LS after preoperative evaluation. If difficulties were encountered in LS, one trocar site incision was enlarged to 7-8 cm to engage the left hand for hand-assisted laparoscopic splenectomy (HALS) and the procedure was completed. Various parameters were reported, including spleen size as assessed by ultrasound scan, postoperative mortality and morbidity rates, accessory spleen removal, conversion rate, operative times and length of hospital stay. LS was successfully completed in 9 patients (60%) and HALS was performed in 4 patients (26.6%). Two patients required conversion to open splenectomy.


RESULTS
The mean operative time was 209 min and the mean hospital stay was 8.1 days. The hospital stay was significantly longer among HALS patients than LS patients. The mean age of patients and splenic size were associated with a significantly higher conversion rate. No deaths were attributed to the procedure. Complications occurred in 2 of 15 patients. Accessory spleens were identified in 2 patients.


CONCLUSIONS
LS is both a safe and feasible procedure, but it requires great technical care to avoid serious complications.
Khoursheed
M
M
Department of Surgery, Faculty of Medicine, Kuwait University, Kuwait. khoursheed@hsc.kuniv.edu.kw
Al-Sayegh
F
F
Al-Bader
I
I
Kanawati
N
N
Maroof
R
R
Asfar
S
S
Dashti
H
H
D000293:Adolescent; D000328:Adult; D005260:Female; D006402:Hematologic Diseases / Q000601:surgery; D006801:Humans; D007730:Kuwait; D010535:Laparoscopy / Q000379:methods; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000601:surgery*; D013154:Spleen / Q000473:pathology*; D013156:Splenectomy / Q000379:methods; D013789:Thalassemia / Q000601:surgery*; D016896:Treatment Outcome